Skip to Main Content

Marcia Leavitt/Iris Cantor-UCLA for Women's Cervical Cancer Research

The information below is from the 2020 request for proposals. Please see the opportunity website for updated information. 

The Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health seeks to promote comprehensive health care for women by providing support for research to understand human sex differences in health and disease and medical issues and diseases unique to women, as well as to develop and test clinical interventions for women. An equally important component of the Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health mission is training future leaders in women’s health research.

Pilot funding is available for research related to the prevention and treatment of cervical cancer. Basic scientists, clinical researchers, and public health and health services researchers are strongly encouraged to apply.

The Iris Cantor-UCLA Women’s Health Center invites submission of projects for pilot funding addressing the following issues:

  • To encourage and support research, including interdisciplinary research, in the field of cervical cancer, including:
    • To promote basic science research on cervical cancer , including, but not limited to, genomics, carcinogenesis (cofactors), and the natural history of human papillomavirus infection
    • To study the effectiveness of new strategies to prevent cervical cancer
    • To study the effectiveness of new strategies to screen for cervical cancer
    • To study new treatments for cervical cancer
    • To use established methods of health, utility, and cost measurement to assess and suggest ways to improve the effectiveness of cervical cancer prevention, screening, and treatment
  • To train researchers capable of leading and conducting cervical cancer research programs
  • To extend resources to increase the quality of cervical cancer research throughout UCLA and affiliated institutions

Please note that highest priority for the pilots will be given to pilots that would likely lead to R01s (or equivalent level funding from extramural sources) within 2-3 years.

Go to Application Homepage

Award Amount and Details

Award Amount
$75,000
Award Details
  • Funding Amount Available: Up to $75,000 for a two year period. 
    • Investigators may request up to $50,000 for a one-year period, or $75,000 for a two-year period.
  • Funding may be requested for any purpose which meets the needs of the investigator(s) and complies with UCLA policies for expenditure of funds. 
  • Successful applicants may be asked to attend a team science training.

Deadlines and Date Information

Due Date
2020-01-22

The due dates listed below are the most recent due dates our office is aware of. Please see the opportunity home page for information about potential upcoming deadlines or other opportunities. 

Submission Timeline 

  • Due Wednesday, January 22nd, 2020 by noon 
    • One-page letter of intent (LOI) and NIH biosketch(es)
    • The letter of intent, biosketch(s), and other attachments should be e-mailed to the attention of Audree Hsu, audreehsu@mednet.ucla.edu. The letter of intent, biosketch(s), and other requested materials must be received by noon, Wednesday, January 22nd, 2020.
  • By Monday, March 16th, 2020: The Review Committee will review letters of intent and contact investigators whom they wish to submit full pilot proposals.
  • July 1, 2020: Funded projects will begin for the period July 1, 2020 through June 30, 2022.

Eligibility Information

Who's Eligible
Academic appointees
Members of the Academic Senate
Information Source
Information provided by administering unit

Administering Unit
David Geffen School of Medicine at UCLA (DGSOM)
Funding Type
Research
Changed
December 20, 2022
Important Note These opportunities have been collated for the benefit of the campus community, but in all cases viewers should refer to the pages of the hosting unit for the most current/accurate information.